- call +1-201-465-4211
- email sales@mrinsights.biz
3D printing first got widespread public attention in 2013, when it was specifically mentioned by President Obama in his State of the Union Address. 3D printing is a manufacturing process where an object is created with the help of a layer-by-layer material approach. Each layer can be considered a thin horizontal cross-section of the final product. It uses Computer Aided Design (CAD) i.e. a digital blueprint to create rapid prototypes, spare parts and final products. 3D printing uses materials like thermoplastics, plastic composites, metals, alloys, ceramics etc. 3D printing as an end-use manufacturing technology is still not fully developed but it has the potential to transform the conception, manufacturing and logistics processes.
Scope of the Report:
This report studies the 3D Bioprinting for Life Science R&D market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the 3D Bioprinting for Life Science R&D market by product type and applications/end industries.
The drug testing market is likely to be the main driver of the 3D Bioprinting for Life Science R&D Market. Since 2011, a group of U.S government agencies have been investing in something known as ‘Human on a chip’ or ‘Body on a chip’. The objective is to create a miniature human organ system that mimics the bodily response to harmful agents, enabling the development of potential therapies. The pharmaceutical industry could use such equipment to test drugs more efficiently due to human stem cells and at a much lower cost. It would also be less risky.
The second 3D Bioprinting for Life Science R&D Market driver could be patients wanting to print personalised medicine at home which matches their genetic profile or medical history. This may well be one of the most profound business transformations in the pharmaceutical industry. While it is still in the early stages, the cost advantages and the quality outcome could be massive indeed.
The global 3D Bioprinting for Life Science R&D market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of 3D Bioprinting for Life Science R&D.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
EnvisionTEC
Regenovo
Organovo
3D Systems
3D Biotek
Advanced Biomatrix
Digilab
Nano3D Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Magnetic 3D Bioprinting
Laser-Assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Market Segment by Applications, can be divided into
Clinical
Research
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 3D Bioprinting for Life Science R&D Market Overview
1.1 Product Overview and Scope of 3D Bioprinting for Life Science R&D
1.2 Classification of 3D Bioprinting for Life Science R&D by Types
1.2.1 Global 3D Bioprinting for Life Science R&D Revenue Comparison by Types (2017-2023)
1.2.2 Global 3D Bioprinting for Life Science R&D Revenue Market Share by Types in 2017
1.2.3 Magnetic 3D Bioprinting
1.2.4 Laser-Assisted Bioprinting
1.2.5 Inkjet 3D Bioprinting
1.2.6 Microextrusion 3D Bioprinting
1.3 Global 3D Bioprinting for Life Science R&D Market by Application
1.3.1 Global 3D Bioprinting for Life Science R&D Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Clinical
1.3.3 Research
1.4 Global 3D Bioprinting for Life Science R&D Market by Regions
1.4.1 Global 3D Bioprinting for Life Science R&D Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) 3D Bioprinting for Life Science R&D Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) 3D Bioprinting for Life Science R&D Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 3D Bioprinting for Life Science R&D Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) 3D Bioprinting for Life Science R&D Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) 3D Bioprinting for Life Science R&D Status and Prospect (2013-2023)
1.5 Global Market Size of 3D Bioprinting for Life Science R&D (2013-2023)
2 Manufacturers Profiles
2.1 EnvisionTEC
2.1.1 Business Overview
2.1.2 3D Bioprinting for Life Science R&D Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 EnvisionTEC 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
2.2 Regenovo
2.2.1 Business Overview
2.2.2 3D Bioprinting for Life Science R&D Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Regenovo 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
2.3 Organovo
2.3.1 Business Overview
2.3.2 3D Bioprinting for Life Science R&D Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Organovo 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
2.4 3D Systems
2.4.1 Business Overview
2.4.2 3D Bioprinting for Life Science R&D Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 3D Systems 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
2.5 3D Biotek
2.5.1 Business Overview
2.5.2 3D Bioprinting for Life Science R&D Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 3D Biotek 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
2.6 Advanced Biomatrix
2.6.1 Business Overview
2.6.2 3D Bioprinting for Life Science R&D Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Advanced Biomatrix 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
2.7 Digilab
2.7.1 Business Overview
2.7.2 3D Bioprinting for Life Science R&D Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Digilab 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
2.8 Nano3D Biosciences
2.8.1 Business Overview
2.8.2 3D Bioprinting for Life Science R&D Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Nano3D Biosciences 3D Bioprinting for Life Science R&D Revenue, Gross Margin and Market Share (2016-2017)
3 Global 3D Bioprinting for Life Science R&D Market Competition, by Players
3.1 Global 3D Bioprinting for Life Science R&D Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 3D Bioprinting for Life Science R&D Players Market Share
3.2.2 Top 10 3D Bioprinting for Life Science R&D Players Market Share
3.3 Market Competition Trend
4 Global 3D Bioprinting for Life Science R&D Market Size by Regions
4.1 Global 3D Bioprinting for Life Science R&D Revenue and Market Share by Regions
4.2 North America 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
4.3 Europe 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
4.5 South America 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
5 North America 3D Bioprinting for Life Science R&D Revenue by Countries
5.1 North America 3D Bioprinting for Life Science R&D Revenue by Countries (2013-2018)
5.2 USA 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
5.3 Canada 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
5.4 Mexico 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
6 Europe 3D Bioprinting for Life Science R&D Revenue by Countries
6.1 Europe 3D Bioprinting for Life Science R&D Revenue by Countries (2013-2018)
6.2 Germany 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
6.3 UK 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
6.4 France 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
6.5 Russia 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
6.6 Italy 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
7 Asia-Pacific 3D Bioprinting for Life Science R&D Revenue by Countries
7.1 Asia-Pacific 3D Bioprinting for Life Science R&D Revenue by Countries (2013-2018)
7.2 China 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
7.3 Japan 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
7.4 Korea 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
7.5 India 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
8 South America 3D Bioprinting for Life Science R&D Revenue by Countries
8.1 South America 3D Bioprinting for Life Science R&D Revenue by Countries (2013-2018)
8.2 Brazil 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
8.3 Argentina 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
8.4 Colombia 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue 3D Bioprinting for Life Science R&D by Countries
9.1 Middle East and Africa 3D Bioprinting for Life Science R&D Revenue by Countries (2013-2018)
9.2 Saudi Arabia 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
9.3 UAE 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
9.4 Egypt 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
9.5 Nigeria 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
9.6 South Africa 3D Bioprinting for Life Science R&D Revenue and Growth Rate (2013-2018)
10 Global 3D Bioprinting for Life Science R&D Market Segment by Type
10.1 Global 3D Bioprinting for Life Science R&D Revenue and Market Share by Type (2013-2018)
10.2 Global 3D Bioprinting for Life Science R&D Market Forecast by Type (2018-2023)
10.3 Magnetic 3D Bioprinting Revenue Growth Rate (2013-2023)
10.4 Laser-Assisted Bioprinting Revenue Growth Rate (2013-2023)
10.5 Inkjet 3D Bioprinting Revenue Growth Rate (2013-2023)
10.6 Microextrusion 3D Bioprinting Revenue Growth Rate (2013-2023)
11 Global 3D Bioprinting for Life Science R&D Market Segment by Application
11.1 Global 3D Bioprinting for Life Science R&D Revenue Market Share by Application (2013-2018)
11.2 3D Bioprinting for Life Science R&D Market Forecast by Application (2018-2023)
11.3 Clinical Revenue Growth (2013-2018)
11.4 Research Revenue Growth (2013-2018)
12 Global 3D Bioprinting for Life Science R&D Market Size Forecast (2018-2023)
12.1 Global 3D Bioprinting for Life Science R&D Market Size Forecast (2018-2023)
12.2 Global 3D Bioprinting for Life Science R&D Market Forecast by Regions (2018-2023)
12.3 North America 3D Bioprinting for Life Science R&D Revenue Market Forecast (2018-2023)
12.4 Europe 3D Bioprinting for Life Science R&D Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific 3D Bioprinting for Life Science R&D Revenue Market Forecast (2018-2023)
12.6 South America 3D Bioprinting for Life Science R&D Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa 3D Bioprinting for Life Science R&D Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure 3D Bioprinting for Life Science R&D Picture
Table Product Specifications of 3D Bioprinting for Life Science R&D
Table Global 3D Bioprinting for Life Science R&D and
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
